Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05968079 · ClinicalTrials.gov registry record
Performance Comparison Between Masimo W1™ and Apple Watch Series 8
A clinical trial, sponsored by Masimo Corporation.
- Completed
- Registry status
- 20
- Enrollment target
NCT05968079: Completed study, sponsored by Masimo Corporation.
NCT05968079 is a clinical trial that has completed, run by Masimo Corporation. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05968079 has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study is also designed to compare the performance of Masimo W1™ and Apple Watch Series 8 against FDA cleared hospital grade pulse oximetry technology under desaturation conditions.
Primary Outcome
Accuracy will be determined by comparing Masimo W1™ SpO2 measurements and Apple Watch Series 8 SpO2 measurements with FDA-cleared pulse oximetry device SpO2 measurements and calculating the Arithmetic root mean square (ARMS) value. All values presented below for SpO2 (Bias, Precision and ARMS) are in units of %. The pairwise samples consist of paired SpO2 timing measurements from both the reference sensor, Masimo W1, and the Apple Watch.
Interventions
- DEVICE Masimo W1™ and Apple Watch Series 8
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2023-10-11 |
What the finished NCT05968079 record still lists
NCT05968079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Masimo W1™ and Apple Watch Series 8 is the first listed.
NCT05968079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05968079 about?
NCT05968079 is a clinical study titled "Performance Comparison Between Masimo W1™ and Apple Watch Series 8". This study is also designed to compare the performance of Masimo W1™ and Apple Watch Series 8 against FDA cleared hospital grade pulse oximetry technology under desaturation conditions.
What is the current status of trial NCT05968079?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2023-09-06. Estimated completion is 2023-10-11.
What interventions are being tested in trial NCT05968079?
The interventions under investigation include: Masimo W1™ and Apple Watch Series 8 (DEVICE).
Who is sponsoring clinical trial NCT05968079?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI